Project POLARIS – Addendum zu interventionellen Studie

Basic data

Acronym:
POLARIS
Title:
Addendum zu interventionellen Studie
Duration:
01/12/2016 to 31/08/2018
Abstract / short description:
Addendum No. 2 zur Studie: Multicenter, randomized, open-label, efficacy assessor-blinded, active comparator-controlled phase 3b study to compare the efficacy of guselkumab to fumaric acid esters (Fumaderm initial/Fumaderm) for adult patients with moderate to severe plaque psoriasis who are candidates for and naive to systemic treatment.
Keywords:
dermatology
Dermatologie
psoriasis
Schuppenflechte
psoriasis therapeutics
Psoriasis Therapeutika
clinical trial
klinische Studie

Involved staff

Managers

Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine

Local organizational units

Department of Dermatology
Hospitals and clinical institutes
Faculty of Medicine

Funders

Neuss, Nordrhein-Westfalen, Germany
Help

will be deleted permanently. This cannot be undone.